Women whose breast cancers need estrogen to grow are often treated for five or more years with medications to lower estrogen production or block its effects. Broadly known as endocrine therapy, the ...
An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...
Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...
Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...
Cancer-free for nearly 20 years, RIT graduate student Bryona Hamilton seeks to educate patients, survivors, and family ...